Photoinduced Mild Hyperthermia and Synergistic Chemotherapy by One-Pot-Synthesized Docetaxel-Loaded Poly(lactic-co-glycolic acid)/Polypyrrole Nanocomposites

Mild hyperthermia-has shown great advantages when, combined with chemotherapy. The development of a multifunctional platform for the integration of mild hyperthermia capability into a drug-loading system is 4 key issue for cancer multimodality treatment application. Herein, 4 facile one-pot in situ fabrication protocol of ,clocetaxel (DTX),,loaded poly(lactic-coglycolic acid) (PLGA)/poly: pyrrole (PPy) nanocomposites was developed. While the PLGA nanoparticles (NPs) allow efficient drug loading, the PPy nanobulges embedded within the surface of the PLGA NPs, formed by in situ Pyrrole polymerization without the introduction of other template agents, can act as ideal mediators for-photoinduced mild hyperthermia. Physiochemical Characterizations,of the as-prepared nanocomposites, including structure, morphology, photothermal effects, and an in vitro. drug release profile, were systematically investigated. Further, 2-deoxyglucose-terminated polyethylene glycol) (PEG) was anchored onto the surface of the nanocomposites to endow the nanoplatform with targeting ability to tumor cells, which resulted in a, 17-fold increase Of NP internalization-within human breast cancer cells (MCP-7) as competed With PEG-modified nanocomposites. Mild hyperthermia can be successfully mediated by the nanoplatform, and the temperature can be conveniently,controlled :by careful modulation,of the PPy contents within the nanocomposites or the laser power density. Importantly, we have demonstrated that MCF-7 cells, which are markedly resistant to heat treatment of traditional water-bath hyperthermia, became sensitive to the PLGA/PPy nanocomposite-mediated photothermal therapy under the same mild-temperature hyperthermia. Moreover, DTX-loaded PLGA/PPy-nanocomposite-induced mild hyperthermia can strongly enhance drug cytotoxicity to MCF-7 cells. Under the same thermal dose, photoinduced hyperthermia can convert the interaction between hyperthermia and drug treatment from interference to, synergism. This is-the first report on-the one-pot synthesis of PLGA/PPy nanocomposites by in situ pyrrole polymerization, and such a, multifunctional nanoplatform is demonstrated as a high-potential agent for photoincluced mild hyperthermia and enhanced chemotherapy.